What is the latest MAXHEALTH stock price?
The latest stored price for MAXHEALTH is Rs 1,009.90 as of 2026-11-16.
MAX HEALTHCARE INS LTD is a large-cap stock in Healthcare. This Gimli page shows the latest available MAXHEALTH price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for MAXHEALTH is Rs 1,009.90 as of 2026-11-16.
MAXHEALTH is above 50DMA, above 200DMA. The latest 50DMA is 938.45 and the latest 200DMA is 1,009.64.
MAXHEALTH has PE 71.19, ROE +13.72%, and ROCE +15.61% in Gimli's latest available snapshot.
MAXHEALTH has returned +19.37% over 1 month, +0.13% over 3 months, and -8.45% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 2,569.21 cr | 752.39 cr | 414.94 cr | 4.26 |
| 2026-06-30 | 2,366.17 cr | 638.97 cr | 322.96 cr | 3.32 |
| 2026-03-31 | 2,142.89 cr | 654.26 cr | 342.22 cr | 3.52 |
| 2025-12-31 | 2,067.52 cr | 535.48 cr | 300.92 cr | 3.10 |
| 2025-09-30 | 2,135.47 cr | 608.05 cr | 491.30 cr | 5.05 |
| 2025-06-30 | 2,027.57 cr | 559.42 cr | 307.97 cr | 3.17 |
| 2025-03-31 | 1,909.74 cr | 558.54 cr | 319.00 cr | 3.28 |
| 2024-12-31 | 1,868.31 cr | 458.80 cr | n/a | nan |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 8,373.45 cr | 2,357.21 cr | 1,442.41 cr | 7.33 |
| 2025-03-31 | 7,028.46 cr | 1,930.81 cr | 1,075.88 cr | 11.07 |
| 2024-03-31 | 5,309.48 cr | 1,654.86 cr | 1,057.64 cr | 10.89 |
| 2023-03-31 | 4,488.95 cr | 1,367.23 cr | 1,103.51 cr | 11.38 |
| 2022-03-31 | 1,903.48 cr | 1,050.03 cr | 331.52 cr | 6.25 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 17,230.94 cr | 665.80 cr | 3,478.36 cr | 10,746.63 cr |
| 2025-03-31 | 15,214.48 cr | 661.58 cr | 3,010.29 cr | 9,380.87 cr |
| 2024-03-31 | 11,999.94 cr | 979.84 cr | 1,294.56 cr | 8,408.14 cr |
| 2023-03-31 | 10,101.85 cr | 1,374.33 cr | 908.25 cr | 7,409.59 cr |
| 2022-03-31 | 9,189.13 cr | 309.14 cr | 1,138.62 cr | 6,282.47 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,633.32 cr | 148.79 cr | n/a |
| 2025-03-31 | 1,437.96 cr | 493.48 cr | n/a |
| 2024-03-31 | 1,121.67 cr | 335.72 cr | n/a |
| 2023-03-31 | 1,284.13 cr | 948.52 cr | n/a |
| 2022-03-31 | 740.52 cr | 187.18 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +23.71% | +40.52% | +31.00% | +19.25% | +4.76% | +0.00% |
| 2026-06-30 | +23.71% | +41.78% | +29.96% | +18.68% | +4.56% | +0.00% |
| 2026-03-31 | +23.71% | +45.39% | +26.32% | +16.30% | +4.57% | +0.00% |
| 2025-12-31 | +23.72% | +50.55% | +21.20% | +14.04% | +4.52% | +0.00% |
| 2025-09-30 | +23.74% | +51.80% | +20.03% | +14.25% | +4.43% | +0.00% |
| 2025-06-30 | +23.74% | +54.76% | +17.42% | +12.54% | +4.08% | +0.00% |
| 2025-03-31 | +23.74% | +54.74% | +17.58% | +13.38% | +3.94% | +0.00% |
| 2024-12-31 | +23.74% | +56.93% | +15.55% | +11.72% | +3.77% | +0.00% |
| 2024-09-30 | +23.74% | +57.29% | +15.14% | +11.56% | +3.83% | +0.00% |
| 2024-06-30 | +23.74% | +56.98% | +15.36% | +12.19% | +3.91% | +0.00% |
| 2024-03-31 | +23.75% | +57.33% | +14.96% | +12.33% | +3.96% | +0.00% |
| 2023-12-31 | +23.75% | +60.69% | +11.57% | +10.62% | +3.99% | +0.00% |
| 2023-09-30 | +23.76% | +60.38% | +11.40% | +10.55% | +4.46% | +0.00% |
| 2023-06-30 | +23.76% | +59.89% | +11.90% | +11.32% | +4.46% | +0.00% |
| 2023-03-31 | +23.77% | +51.95% | +19.35% | +18.88% | +4.93% | +0.00% |
| 2022-12-31 | +23.78% | +50.14% | +20.47% | +20.00% | +5.61% | +0.00% |
| 2022-09-30 | +23.80% | +49.27% | +21.17% | +20.86% | +5.76% | n/a |
| 2022-06-30 | +50.64% | +0.00% | +42.76% | n/a | n/a | +51.15% |
| 2022-03-31 | +50.64% | +0.00% | +32.16% | n/a | n/a | +51.15% |
| 2021-12-31 | +60.68% | +0.00% | +32.34% | n/a | n/a | +42.69% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.